Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease.
 
Epigenetics is nature’s central mechanism for gene regulation, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the world’s foremost genomic medicine experts, Chroma Medicine is working at the cutting edge of precision genomics, building an entirely new class of therapeutics to achieve unparalleled control of gene expression.
 
*Note: Be aware of fraudulent recruiting advertisements and scams: Potential candidates for employment at Chroma Medicine should be aware of job offer fraud scams perpetrated through the use of the internet and social media platforms. To learn more, please visit the Join Us page on our website.

Casdin Capital

Wellington Management

T. Rowe Price

Janus Henderson Investors

Omega Funds

Cormorant Asset Management

Sixth Street Partners

Mubadala Capital Ventures

Newpath Management

Alexandria Venture Investments

ARCH Venture Partners

Atlas Venture

DCVC Bio

Chroma Medicine

During #AmericanHeartMonth this February, Chroma is committed to spreading awareness and encouraging daily proactive steps for #OurHearts. Studies show that just 30 minutes of daily exercise can significantly reduce your risk of a heart attack. 

We invite you to #LoveYourHeart and participate in a nearby #HeartWalk: https://lnkd.in/eYxZcHu

During today's Keystone Symposia on Precision Genome Engineering, Morgan Maeder, PhD, Senior Director of Payload Sciences, will present on the therapeutic development of #EpigeneticEditors, highlighting the potential of our approach for enabling treatment of serious diseases. Hope to see you there!

#KSGenomeEng24 
#EpigeneticEditing
#PrecisionGenomeEngineering
#Biotech

Join us next week at the Keystone Precision Genome Engineering conference where Morgan Maeder, PhD, Senior Director of Payload Sciences, will present on the development of therapeutic #EpigeneticEditors. Looking forward to connecting with colleagues and learning more about the latest breakthroughs in genomic medicine.
 
Register to attend: http://bit.ly/48sxD4w

#KSGenomeEng24
#PrecisionGenomeEngineering
#EpigeneticEditing
#Biotech

While many of us will enjoy a slow down next week, we are deeply grateful to our dedicated scientists who will keep key experiments running so we can continue to make advancements in #EpigeneticEditing in 2024.

Wishing you and your loved ones a cheerful and healthy holiday season and New Year! 

#HappyHolidays 

Cultivating curiosity and learning is central to Chroma’s culture. Through our partnership with Northeastern University’s co-op program, we provide students with meaningful experiences in cutting-edge biotech. Our second cohort did an outstanding job and recently presented their capstone poster projects to the entire Chroma team, highlighting their work over the past 6 months.

Thank you to our co-ops for all of your contributions, and best of luck in your classes and future endeavors!

#EpigeneticEditing
#Biotech
#CoOp
#Internship

Moonwalk is a biotechnology company focused on developing therapies utilizing epigenetic editing technology.

Moonwalk

FOXO BioScience is a biotech company specializing in epigenetic editing technology for therapeutic applications.

FOXO BioScience

Epigenica is a biotech firm dedicated to the development of therapies based on epigenetic editing technology.

Epigenica

Chroma Medicine is a biotechnology company focused on discovering and developing therapies that harness the power of epigenetic mechanisms to treat diseases. Their approach involves targeting gene regulation to potentially cure a range of diseases at their source.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 9:40 AM	a3ec9732
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	6faa58d9
crunchbase profile	general	Nov 22, 2024 9:29 AM	60125a36
li profile	general	May 16, 2024 9:40 AM	05a88a43
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CHROMAMEDICINE

Chroma Medicine